Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Current Deferred Revenue of $284000.0 for Q1 2026, down 55.69% year-over-year from $641000.0 in Q1 2025, and up 91.89% quarter-over-quarter from $148000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Current Deferred Revenue history runs 16 years deep, the most recent figure standing at $284000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 55.69% year-over-year to $284000.0; the TTM figure through Mar 2026 stood at $284000.0 (down 55.69% YoY), while the FY2026 annual figure was $284000.0, down 55.69% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $284000.0, up from $148000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $1.2 million in Q1 2022, with the low at $75000.0 in Q4 2023.
- The 5-year median for Current Deferred Revenue is $220000.0 (2024), against an average of $356000.0.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue soared 358.05% in 2022, then sank 83.73% in 2023.
- Sonoma Pharmaceuticals' Current Deferred Revenue stood at $100000.0 in 2022, then retreated by 25.0% to $75000.0 in 2023, then jumped by 302.67% to $302000.0 in 2024, then tumbled by 50.99% to $148000.0 in 2025, then soared by 91.89% to $284000.0 in 2026.
- Business Quant data shows SNOA's Current Deferred Revenue at $284000.0 in Q1 2026, $148000.0 in Q4 2025, and $750000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 282,000.00 |
| Mar 31, 2026 | 284,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Sep 30, 2025 | 750,000.00 |
| Jun 30, 2025 | 731,000.00 |
| Mar 31, 2025 | 641,000.00 |
| Dec 31, 2024 | 302,000.00 |
| Sep 30, 2024 | 220,000.00 |
| Jun 30, 2024 | 413,000.00 |
| Mar 31, 2024 | 565,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 101,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 199,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |